Big Move For MiNK Therapeutics Inc.

Wed, Oct 04, 2023 at 08:02 PM

MiNK Therapeutics Inc. (INKT:NASDAQ) shot up at $1.14, representing a gain of 30.3%. The stock got featured on our News Catalysts scanner on Thu, Sep 28, 2023 at 04:53 AM in the 'MISCELLANEOUS' category. From Wed, Sep 20, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days

About MiNK Therapeutics Inc. (INKT:NASDAQ)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...

Top 10 Gainers:

Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
Vivos Therapeutics Inc. (VVOS:NASDAQ), 63.71%
LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 63.29%
Rubicon Technology, Inc. (RBCN:NASDAQ), 49.61%
Nuvalent Inc. (NUVL:NASDAQ), 35.57%
Histogen Inc. (HSTO:NASDAQ), 31.6%
MiNK Therapeutics Inc. (INKT:NASDAQ), 30.29%
Spectral AI Inc. (MDAI:NASDAQ), 29.51%
Mercato Partners Acquisition Corporation (MPRA:NASDAQ), 23.23%
AquaBounty Technologies, Inc. (AQB:NASDAQ), 22.03%